Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
Crossref DOI link:
Published Online: 2016-09-30
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hood, Robert C.
DeLozier, Amy M.
Funding for this research was provided by:
Eli Lilly and Company